A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 945,049 shares of TEVA stock, worth $15.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
945,049
Previous 956,337 1.18%
Holding current value
$15.6 Million
Previous $9.98 Million 33.55%
% of portfolio
0.09%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $120,442 - $162,885
-11,288 Reduced 1.18%
945,049 $13.3 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $502,108 - $657,316
61,836 Added 6.91%
956,337 $9.98 Million
Q3 2023

Nov 15, 2023

BUY
$7.48 - $10.7 $1.56 Million - $2.23 Million
208,776 Added 30.45%
894,501 $9.12 Million
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $3.4 Million - $4.47 Million
-472,253 Reduced 40.78%
685,725 $5.16 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $99,141 - $134,836
11,859 Added 1.03%
1,157,978 $10.2 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $167,204 - $199,383
21,032 Added 1.87%
1,146,119 $10.5 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $68,600 - $119,500
10,000 Added 0.9%
1,125,087 $9.08 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $3.06 Million - $4.32 Million
415,000 Added 59.28%
1,115,087 $8.39 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $5.13 Million - $6.57 Million
700,087 New
700,087 $6.57 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $87,598 - $112,320
-10,174 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $87,191 - $129,108
10,174 New
10,174 $92,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $82,011 - $132,512
-10,100 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $3,318 - $6,671
-496 Reduced 4.68%
10,100 $91,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $69,191 - $113,589
10,596 New
10,596 $104,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.